deltatrials
Unknown PHASE3 NCT00713739

Alfuzosin for Medical Expulsion Therapy of Ureteral Stones

Evaluation of Alfuzosin as Medical Expulsion Therapy for Ureteral Stones

Sponsor: United States Naval Medical Center, San Diego

Conditions Kidney Stones
Interventions Alfuzosin doxazosin nifedipine prazosin
Updated 5 times since 2017 Last updated: Apr 25, 2012 Started: Jan 31, 2008 Primary completion: Dec 31, 2010 Completion: Dec 31, 2012

This PHASE3 trial investigates Kidney Stones and is currently ongoing. United States Naval Medical Center, San Diego leads this study, which shows 5 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE3

    First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • United States Naval Medical Center, San Diego
Data source: United States Naval Medical Center, San Diego

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • San Diego, United States